BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10819555)

  • 1. A case of toxic epidermal necrolysis treated with intravenous immunoglobin.
    Magina S; Lisboa C; Gonçalves E; Conceição F; Leal V; Mesquita-Guimarães J
    Br J Dermatol; 2000 Jan; 142(1):191-2. PubMed ID: 10819555
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins.
    Paquet P; Jacob E; Damas P; Piérard GE
    Burns; 2001 Sep; 27(6):652-5. PubMed ID: 11525863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole-induced Stevens-Johnson syndrome: a case report.
    Langlois MR; Derk F; Belczyk R; Zgonis T
    J Am Podiatr Med Assoc; 2010; 100(4):299-303. PubMed ID: 20660883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patch testing in an unusual case of toxic epidermal necrolysis.
    Klein CE; Trautmann A; Zillikens D; Bröcker EB
    Contact Dermatitis; 1996 Sep; 35(3):175-6. PubMed ID: 8930481
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful intravenous human immunoglobulin treatment of drug-induced Stevens-Johnson syndrome in a dog.
    Nuttall TJ; Malham T
    J Small Anim Pract; 2004 Jul; 45(7):357-61. PubMed ID: 15266858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yeung CK; Lam LK; Chan HH
    Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic epidermal necrolysis. A widespread, life-threatening blistering reaction.
    Watanakunakorn P; Brodell RT
    Postgrad Med; 2000 Apr; 107(4):29-30. PubMed ID: 10778408
    [No Abstract]   [Full Text] [Related]  

  • 9. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fromowitz JS; Ramos-Caro FA; Flowers FP;
    Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis and co-trimoxazole.
    Whittington RM
    Lancet; 1989 Sep; 2(8662):574. PubMed ID: 2570281
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological skin covers in treatment of two cases of the Lyell's syndrome.
    Klein L; Mĕricka P; Straková H; Jebavý L; Nozicková M; Bláha M; Talábová Z; Hosek F
    Ann Transplant; 1997; 2(1):45-8. PubMed ID: 9869841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
    Kelly JP; Kaufman DW; Dunant A; Mockenhaupt M; Roujeau JC
    J Am Acad Dermatol; 2011 Jun; 64(6):1193-4. PubMed ID: 21571188
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of macrophage migration inhibition factor in toxic epidermal necrolysis.
    Halevy S; Livni E
    Int J Dermatol; 1997 Oct; 36(10):776-8. PubMed ID: 9372356
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Stern RS
    Arch Dermatol; 2000 Mar; 136(3):410-1. PubMed ID: 10724207
    [No Abstract]   [Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wildermuth A
    JAAPA; 2020 Aug; 33(8):48-49. PubMed ID: 32740115
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of intravenous immunoglobulin in toxic epidermal necrolysis.
    Feldmeyer L; Kerdel FA; French LE
    Arch Dermatol; 2011 Dec; 147(12):1440-1. PubMed ID: 22184768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.